A Phase 1, Open-label, Exploratory, Fixed-sequence, Pharmacokinetic Single Ascending Dose Study of IVL3004 Versus VIVITROL® (Naltrexone) Long-acting Injectable (LAI) in Healthy Subjects

Real-world Benefits and Tolerability of Trofinetide for the Treatment of Adults with Rett Syndrome: the LOTUS Study

Author:Cosand, Louise   Bucco, Ryan   

Session Name:P11: General Neurology: Pharmaceuticals  

Topic:General Neurology  

Program Number:P11.005  

Author Institution:Acadia Pharmaceuticals Inc., CA